These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16862521)

  • 1. An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation.
    Meijer P; Haverkate F
    Semin Thromb Hemost; 2006 Jul; 32(5):485-91. PubMed ID: 16862521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
    Favaloro EJ; Bonar R; Marsden K
    Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program.
    Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Baker R; Hertzberg M; Street A; Marsden K
    Semin Thromb Hemost; 2006 Jul; 32(5):505-13. PubMed ID: 16862524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.
    Hayes TE; Brandt JT; Chandler WL; Eby CS; Kottke-Marchant K; Krishnan J; Lefkowitz JB; Olson JD; Rund CR; Van Cott EM; Cunningham MT
    Semin Thromb Hemost; 2006 Jul; 32(5):499-504. PubMed ID: 16862523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.
    Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Thom J; Baker R; Hertzberg M; Street A; Lloyd J; Marsden K;
    Lab Hematol; 2005; 11(2):91-7. PubMed ID: 16024332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process.
    Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
    Haemophilia; 2004 May; 10(3):232-42. PubMed ID: 15086320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.
    Favaloro EJ; Bonar R; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
    Am J Clin Pathol; 2003 Jun; 119(6):882-93. PubMed ID: 12817437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD.
    Favaloro EJ; Bonar R; Meiring M; Street A; Marsden K;
    Thromb Haemost; 2007 Aug; 98(2):346-58. PubMed ID: 17721617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
    Favaloro EJ
    Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of von Willebrand disease.
    Patzke J; Schneppenheim R
    Hamostaseologie; 2010 Nov; 30(4):203-6. PubMed ID: 21057713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U; Drewke E; Mainusch K; Schneppenheim R
    Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.